In Vitro Suppression of the Lipogenic Pathway by the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz in 3T3 and Human Preadipocytes or Adipocytes

This publication has 74 references indexed in Scilit:

• Differential effect of HIV protease inhibitors on adipogenesis
  AIDS, 2003
• Efavirenz‐Associated Severe Hyperlipidemia
  Clinical Infectious Diseases, 2002
• HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the Nucleus
  Journal of Biological Chemistry, 2001
• Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors
  Clinical Pharmacokinetics, 2001
• Preliminary Experience of Adverse Drug Reactions, Tolerability, and Efficacy of a Once-Daily Regimen of Antiretroviral Combination Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Cerebrospinal Fluid Human Immunodeficiency Virus Type 1 (HIV‐1) Suppression and Efavirenz Drug Concentrations in HIV‐1–Infected Patients Receiving Combination Therapy
  The Journal of Infectious Diseases, 1999
• Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine
  AIDS, 1998
• Sterol Regulation of Fatty Acid Synthase Promoter
  Journal of Biological Chemistry, 1995
• Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase
  Endocrinology, 1994
• A Method for Isolation of Intact, Translationally Active Ribonucleic Acid
  DNA, 1983